Literature DB >> 11912174

Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase.

Wolfgang Wick1, Antje Wick, Jörg B Schulz, Johannes Dichgans, Hans P Rodemann, Michael Weller.   

Abstract

Sublethal doses of irradiation enhance the invasiveness of human malignantglioma cells. This can be inhibited by subtoxic concentrations of temozolomide (TMZ) but not by lomustine. Antagonism of irradiation-induced motility by TMZ is associated with the prevention of irradiation-induced alpha(v)beta(3)-integrin, matrix metalloproteinase-2 and MT1-matrix metalloproteinase-expression. Irradiation induces focal adhesion kinase (FAK) activation by phosphorylation, whereas TMZ promotes FAK cleavage. Inhibition of caspases prevents TMZ-induced FAK processing and restores the promigratory effect of irradiation, suggesting that the resistance of glioma cells to irradiation-induced caspase processing may determine the invasive responses of glioma cells to irradiation. In contrast, DAOY medulloblastoma cells, which respond with caspase activation to irradiation alone, do not show enhanced invasiveness when irradiated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912174

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Tumor cell migration is not influenced by p21 in colon carcinoma cell lines after irradiation with X-ray or (12)C heavy ions.

Authors:  Kristina Goetze; Michael Scholz; Gisela Taucher-Scholz; Wolfgang Mueller-Klieser
Journal:  Radiat Environ Biophys       Date:  2010-06-10       Impact factor: 1.925

Review 2.  Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence.

Authors:  Wolfgang Wick; Antje Wick; Markus Weiler; Michael Weller
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 3.  The evolution of chemoradiation for glioblastoma: a modern success story.

Authors:  René-Olivier Mirimanoff
Journal:  Curr Oncol Rep       Date:  2006-01       Impact factor: 5.075

Review 4.  Effects of irradiation on tumor cell survival, invasion and angiogenesis.

Authors:  Odysseas Kargiotis; Aliki Geka; Jasti S Rao; Athanasios P Kyritsis
Journal:  J Neurooncol       Date:  2010-05-07       Impact factor: 4.130

5.  Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme.

Authors:  Christopher J Anker; Richard V Hymas; Lisa J Hazard; Kenneth M Boucher; Randy L Jensen; Dennis C Shrieve
Journal:  J Neurooncol       Date:  2010-04-10       Impact factor: 4.130

6.  Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression.

Authors:  Günter Eisele; Antje Wick; Anna-Carina Eisele; Paul M Clément; Jörg Tonn; Ghazaleh Tabatabai; Adrian Ochsenbein; Uwe Schlegel; Bart Neyns; Dietmar Krex; Matthias Simon; Guido Nikkhah; Martin Picard; Roger Stupp; Wolfgang Wick; Michael Weller
Journal:  J Neurooncol       Date:  2014-01-19       Impact factor: 4.130

7.  Treatment of recurrent metastatic uterine leiomyosarcoma of the spine: a multimodality approach using resection, radiosurgery, and chemotherapy.

Authors:  Michael J Strong; Trevor Rosenlof; Siddhartha Padmanabha; Roy S Weiner; Lee Roy Morgan; Marcus I Ware
Journal:  J Neurosurg Spine       Date:  2015-07-17

8.  A novel tool to analyze MRI recurrence patterns in glioblastoma.

Authors:  Wolfgang Wick; Roger Stupp; Anna-Carina Beule; Jacoline Bromberg; Antje Wick; Ulrike Ernemann; Michael Platten; Christine Marosi; Warren P Mason; Martin van den Bent; Michael Weller; Chris Rorden; Hans-Otto Karnath
Journal:  Neuro Oncol       Date:  2008-07-31       Impact factor: 12.300

9.  The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway.

Authors:  Asmaa Sina; Sébastien Proulx-Bonneau; Alain Roy; Laurent Poliquin; Jian Cao; Borhane Annabi
Journal:  J Cell Commun Signal       Date:  2010-01-27       Impact factor: 5.782

Review 10.  Brain endothelial cells as pharmacological targets in brain tumors.

Authors:  Michel Demeule; Anthony Régina; Borhane Annabi; Yanick Bertrand; Michel W Bojanowski; Richard Béliveau
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.